Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Hepatitis D006505 11 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Biliary Tract Diseases D001660 3 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hearing Disorders D006311 10 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Thrombophlebitis D013924 6 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Adenoma D000236 40 associated lipids
Leprosy D007918 8 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
pmid:11483144
Gasche C et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. 2001 Am. J. Gastroenterol. pmid:11513178
pmid:11513584
Murchison LE et al. Effects of anticonvulsants and inactivity on bone disease in epileptics. 1975 Postgrad Med J pmid:1161672
Talafant E et al. Serum gamma-glutamyl transpeptidase activity and urinary D-glucaric acid excretion in newborns in the first week of life. Effects of phenobarbital and nicethamide combination. 1976 Acta Paediatr Scand pmid:11634
Merbouh N et al. Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid. 2001 Carbohydr. Res. pmid:11675028
Chandler G et al. Intravenous iron sucrose: establishing a safe dose. 2001 Am. J. Kidney Dis. pmid:11684551
Kaltwasser JP et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. 2001 J. Rheumatol. pmid:11708414
Duffy CI Iron sucrose or ferric gluconate? 2001 Am. J. Kidney Dis. pmid:11728988
Hörl WH Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 Sep-Oct Perit Dial Int pmid:11757843
pmid:11794536
Cassimos C et al. Urinary D-glucaric acid excretion in children with dystonic reactions caused by antiemetic drugs. 1975 J. Pediatr. pmid:1185409
Bayoumeu F et al. [Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation]. 2002 Ann Fr Anesth Reanim pmid:11878118
Rooyakkers TM et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. 2002 Eur. J. Clin. Invest. pmid:11886426
Kooistra MP et al. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. 2002 Eur. J. Clin. Invest. pmid:11886430
pmid:11887828
Hornez JP et al. [Demonstration of different metabolic pathways starting with glucose or fructose in Rhizobium meliloti]. 1976 C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. pmid:11894
Arteaga de Murphy C et al. 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. 2002 Int J Pharm pmid:11897407
pmid:11903138
Bayoumeu F et al. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. 2002 Am. J. Obstet. Gynecol. pmid:11904617
Marselos M et al. Evidence that D-glucaro-1,4-lactone shortens the pharmacological action of drugs being disposed via the bile as glucuronides. 1975 Biochem. Pharmacol. pmid:1191334
Dittrich E et al. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. 2002 Jan-Feb Perit Dial Int pmid:11929146
Sandstad O et al. D-glucaric acid in common duct bile and relation to choledocholithiasis. 2002 Scand. J. Gastroenterol. pmid:11989842
Ibert M et al. Determination of the side-products formed during the nitroxide-mediated bleach oxidation of glucose to glucaric acid. 2002 Carbohydr. Res. pmid:12039549
Hosoya S et al. Identification and characterization of the Bacillus subtilis D-glucarate/galactarate utilization operon ycbCDEFGHJ. 2002 FEMS Microbiol. Lett. pmid:12044674
Harmankaya O and Eran A Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. 2002 Ren Fail pmid:12071600
Zager RA et al. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. 2002 Am. J. Kidney Dis. pmid:12087566
pmid:12109887
Perewusnyk G et al. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. 2002 Br. J. Nutr. pmid:12117422
Hermida J et al. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment. 2002 Clin. Lab. pmid:12146576
Calcium-D-glucarate. 2002 Altern Med Rev pmid:12197785
Silverberg DS et al. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. 2002 Clin. Nephrol. pmid:12227725
Lecamwasam DS Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man. 1975 Br J Clin Pharmacol pmid:1234021
Lecamwasam DS et al. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. 1975 Br J Clin Pharmacol pmid:1234506
Michaud L et al. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. 2002 Clin Nutr pmid:12381338
Kaizu T [Non-dialyzable beta-glucuronidase inhibitor in guinea-pig urine. I. Purification (author's transl)]. 1975 Yakugaku Zasshi pmid:1238533
Tutor-Crespo MJ et al. [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs]. 2002 Oct 16-31 Rev Neurol pmid:12402220
pmid:12407646
Oldham FB Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable? 2002 Am. J. Kidney Dis. pmid:12407662
Boase S and Miners JO In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. 2002 Br J Clin Pharmacol pmid:12445028
pmid:12455582
Yee J and Besarab A Iron sucrose: the oldest iron therapy becomes new. 2002 Am. J. Kidney Dis. pmid:12460028
Oka H et al. Increased urinary excretion of L-xylulose in patients with liver cirrhosis. 1976 Clin. Chim. Acta pmid:1248150
Bauer S et al. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers. 2002 Eur. J. Clin. Pharmacol. pmid:12483450
Wali A et al. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. 2002 J Pak Med Assoc pmid:12532571
Chuang CL et al. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. 2003 Nephrol. Dial. Transplant. pmid:12543894
Breymann C Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. 2002 Nov-Dec Blood Cells Mol. Dis. pmid:12547241
Escartin Marin P et al. [Enzyme induction in alcoholic and cryptogenetic cirrhoses]. 1976 Rev Esp Enferm Apar Dig pmid:1257561
Folkert VW et al. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration. 2003 Am. J. Kidney Dis. pmid:12612989
Beshara S et al. Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. 2003 Br. J. Haematol. pmid:12614222